AMGEN INC (AMGN)
US0311621009 - Common Stock
Dow Movers: MSFT, AMGN
Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study?
The company is still planning to move into Phase 3 testing, but analysts doubt the pain drug's future.
Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.
Eli Lilly and Viking Therapeutics jumped on Novo's setback.
10 Biggest Losers of The Dow Jones Index's 10-Day Losing Streak
Investors shrugged off the meltdown on Thursday. A few Dow laggards rebounded.
Viridian Therapeutics Skyrockets After Besting Amgen In Thyroid Eye Disease
The company's drug led to an improvement in diplopia, or double vision, an area where Amgen's Tepezza hasn't worked.
Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?
The weight-loss drugs space continues to heat up. Here's the latest news from the segment.
Dow Movers: AMGN, TRV
These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over
AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend...
2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer
2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer
Whether you're looking for a way to beat the benchmark S&P 500 index or you just want a steady flow of passive income, dividend-paying stocks are a great way to achieve your investment goals. During the 50-year period that ended in 2023, dividend-paying stocks in the S&P 500 index delivered a 9.17% average annual return. At recent prices, shares of Coca-Cola (NYSE: KO), and Amgen (NASDAQ: AMGN) offer dividend yields above 3%, plus there's a good chance they'll be able to raise their payouts for many years to come.
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
Looking for reliable income in the stock market? You might want to consider the top Dogs of the Dow in December. Here's what you need to know about this trio of blue-chip stocks.
BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data demonstrating that adding BLINCYTO® (blinatumomab) to chemotherapy significantly improves...
Interesting AMGN Put And Call Options For May 2025
AMGEN ANNOUNCES $1 BILLION MANUFACTURING EXPANSION IN NORTH CAROLINA
/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced a $1 billion expansion to establish a second drug substance manufacturing facility in North Carolina. This...
Is Amgen Still a Top Dividend Stock?
This Healthcare Stock Is a Favorite of Billionaires. But Is It a Buy?
Unsurprisingly, these stock pickers are capitalizing on an opportunity that's only recently become addressable.
Eli Lilly Just Got a Bundle of Good News: Time to Buy?
Market Monitor December 02
AMGEN TO PRESENT AT CITI'S 2024 GLOBAL HEALTHCARE CONFERENCE
/PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Citi's 2024 Global Healthcare Conference at 9:30 a.m. ET on Thursday, Dec. 5, 2024. Peter Griffith,...
Dow Movers: AMGN, AMZN
This Stock Just Dropped by 12% in 1 Day: Should You Buy the Dip?
Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
AMGEN TO PRESENT AT THE 7th ANNUAL EVERCORE HEALTHCONx CONFERENCE
/PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 7th Annual Evercore HealthCONx Conference at 10:00 a.m. ET on Wednesday, Dec. 4, 2024. Peter Griffith,...
Stock Market Hits Highs Despite Trump Tariff Threats, Nvidia, Tech Turkeys: Weekly Review
The Nasdaq isn't at a high, but it isn't far off either.
Is Amgen Stock Still a Buy After an Unexpected Reveal of Data?
